# STUDY INCIDENCE AND CHARACTERISTICS OF MALIGNANT NEOPLASIES IN PATIENTS WITH HEMOGLOBINOPATHY FOLLOWED IN ITALY

> **NCT05286138** · — · RECRUITING · sponsor: **Società Italiana Talassemie ed Emoglobinopatie** · enrollment: 10000 (estimated)

## Conditions studied

- Malignacy, Hemoglobinopathie

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05286138
- **Lead sponsor:** Società Italiana Talassemie ed Emoglobinopatie
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-02-01
- **Primary completion:** 2024-02-28
- **Final completion:** 2052-02-28
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2022-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05286138

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05286138, "STUDY INCIDENCE AND CHARACTERISTICS OF MALIGNANT NEOPLASIES IN PATIENTS WITH HEMOGLOBINOPATHY FOLLOWED IN ITALY". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05286138. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*